Floatz logo

DOMPERIDONE

Diabetes Mellitus

University of LimerickSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

44 Active assets in the Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Erbil Polytechnic University
Phase 4A
Pioglitazone
Milton S. Hershey Medical Center
Phase 4BBB
Alogliptin
Takeda
Phase 3BBB
Glibenclamide
Takeda
Phase 4BBB
Acetylsalicylic Acid
Region Skane
Phase 4BBB

View all 50 →

Same molecule, other indications

DOMPERIDONE is also rated in:

Parkinson diseaseDormant
BB
Indicative ·
69 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
57 / 100
View asset →
secondary progressive multiple sclerosisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →